Thermo Fisher Scientific is trading now at $585.00, down 3.31%, with no clear company-specific announcement identified for August 12, 2026.

  • Recent quarterly results showed $6.03 adjusted EPS and $11.99 billion revenue, with raised 2026 guidance.
  • Reuters reported an India expansion initiative on August 10, not negative news.
  • Broader indexes are higher, so macro sentiment does not clearly explain the decline.